Research

Lowers elevated lipid levels in the blood:

Studies have proved the lipid lowering property of Terminalia Arjuna tree bark. Placebo-controlled clinical trials have shown that regular intake of powdered Terminalia Arjuna bark in the form of supplements caused significant reduction in the LDL and total cholesterol level in people with coronary artery disease within 30 days. (Gupta R et al. “Antioxidant and hypocholesterolaemic effects of Terminalia arjuna tree-bark powder: a randomized placebo-controlled trial.” J Assoc Physicians India. 2001).

Research in reducing frequency and severity of anginal attack:

In a clinical study researchers found that there was significant reduction in the number of angina attacks in patients with stable angina following intake of Arjuna bark powder daily. Furthermore, Arjuna also decreased the elevated blood pressure, stress hormone and cholesterol levels. (Dwivedi S et al. “Antianginal and cardioprotective effects of Terminalia arjuna, an indigenous drug, in coronary artery disease.” J Assoc Physicians India. 1994).

Beneficial for congestive heart failure patients:

Studies have shown that long term use of Arjuna helps in improving the symptoms of congestive heart failure and enhances the quality of life. (Bharani A et al. “Salutary effect of Terminalia Arjuna in patients with severe refractory heart failure.” Int J Cardiol. 1995).

Research in reducing platelet aggregation:

Arjuna inhibits platelet aggregation. The anti-thrombotic activity of Arjuna bark helps in improving blood flow, thereby enhancing cardiac function. (Pingali U et al. “Evaluation of Terminalia arjuna on cardiovascular parameters and platelet aggregation in patients with type 2 diabetes mellitus.” Res J Life Sci 2013).